Trial Profile
Double-blind Placebo-controlled Study of the Effects of Eszopiclone on Glucose Tolerance, Insulin Secretion, and Insulin Action in Adults With Chronic Insomnia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- 28 Mar 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 28 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.